<DOC>
	<DOC>NCT00534339</DOC>
	<brief_summary>Safety, effectiveness, and performance of Allergan's EasyBand telemetrically adjustable gastric banding device for the treatment of morbidly obese patients.</brief_summary>
	<brief_title>EasyBand GOAL Trial</brief_title>
	<detailed_description />
	<mesh_term>Obesity, Morbid</mesh_term>
	<criteria>Minimum 3 year history of morbid obesity with documented failure of conservative, nonsurgical means of weight reduction within 1 year prior to the screening visit; BMI &gt;/= 40 kg/m2, or BMI &gt;/= 35 kg/m2 and &lt;/= 40 kg/m2 with one or more significant medical conditions related to obesity; Candidate for surgical weight loss intervention Previous surgical treatment of obesity; Patient already implanted with a device sensitive to radiofrequency emissions (implantable pacemaker, implantable defibrillator, etc); Physical or emotional conditions that may prohibit surgery</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2010</verification_date>
</DOC>